The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -72.01%.However, over the last six months, we can see a stronger performance of -54.02%. Over the last 30 days, the price of SXTC has fallen by 2.15%. And in the last five days, it has surged by 30.66%.
At present, China SXT Pharmaceuticals Inc. (SXTC) has a stock price of $0.15. In the previous session, the stock saw a rise, peaking at $0.136 after an opening price of $0.1281. The day’s lowest price was $0.115, and it closed at $0.13.
China SXT Pharmaceuticals Inc. experienced a rather shaky stock market performance. The highest value in the past year was recorded at $1.09 on 09/20/22 and the lowest value was $0.11 on 08/28/23.
52-week price history of SXTC Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. China SXT Pharmaceuticals Inc.’s current trading price is -86.06% away from its 52-week high, while its distance from the 52-week low is 44.34%. The stock’s price range during this period has varied between$0.11 and $1.09. The China SXT Pharmaceuticals Inc.’s shares, which operate in the Healthcare, saw a trading volume of around 6.1 million for the day, a figure considerably higher than their average daily volume of 3.88 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
China SXT Pharmaceuticals Inc. (SXTC) has experienced a quarterly decline of -32.88% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.14M and boasts a workforce of 78 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.1950, with a change in price of -0.0471. Similarly, China SXT Pharmaceuticals Inc. recorded 2,867,252 in trading volume during the last 100 days, posting a change of -23.90%.
SXTC’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for SXTC stands at 0.23. Similarly, the long-term debt-to-equity ratio is also 0.01.
SXTC Stock Stochastic Average
China SXT Pharmaceuticals Inc.’s raw stochastic average for the past 50 days is presently 16.64%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 31.93%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 16.98% and 11.28%, respectively.